vs
FIGS, Inc.（FIGS）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是FIGS, Inc.的1.0倍（$207.3M vs $201.9M），FIGS, Inc.净利率更高（9.2% vs -62.0%，领先71.2%），FIGS, Inc.同比增速更快（33.0% vs 25.9%），FIGS, Inc.自由现金流更多（$58.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 30.1%）
FIGS是一家总部位于美国加利福尼亚州圣莫尼卡的服饰企业，由希瑟·哈森与特里娜·斯皮尔于2013年共同创立，二人目前共同担任首席执行官。品牌专注为医疗从业者提供医用刷手服及相关专业产品，是医疗工装领域的知名品牌。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
FIGS vs RARE — 直观对比
营收规模更大
RARE
是对方的1.0倍
$201.9M
营收增速更快
FIGS
高出7.1%
25.9%
净利率更高
FIGS
高出71.2%
-62.0%
自由现金流更多
FIGS
多$158.8M
$-100.8M
两年增速更快
RARE
近两年复合增速
30.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $201.9M | $207.3M |
| 净利润 | $18.5M | $-128.6M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 9.3% | -54.7% |
| 净利率 | 9.2% | -62.0% |
| 营收同比 | 33.0% | 25.9% |
| 净利润同比 | 881.8% | 3.5% |
| 每股收益（稀释后） | $0.10 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FIGSRARE
| Q4 25 | $201.9M | $207.3M | ||
| Q3 25 | $151.7M | $159.9M | ||
| Q2 25 | $152.6M | $166.5M | ||
| Q1 25 | $124.9M | $139.3M | ||
| Q4 24 | $151.8M | $164.6M | ||
| Q3 24 | $140.2M | $139.5M | ||
| Q2 24 | $144.2M | $147.0M | ||
| Q1 24 | $119.3M | $108.8M |
净利润FIGSRARE
| Q4 25 | $18.5M | $-128.6M | ||
| Q3 25 | $8.7M | $-180.4M | ||
| Q2 25 | $7.1M | $-115.0M | ||
| Q1 25 | $-102.0K | $-151.1M | ||
| Q4 24 | $1.9M | $-133.2M | ||
| Q3 24 | $-1.7M | $-133.5M | ||
| Q2 24 | $1.1M | $-131.6M | ||
| Q1 24 | $1.4M | $-170.7M |
毛利率FIGSRARE
| Q4 25 | 62.9% | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | 67.0% | — | ||
| Q1 25 | 67.6% | — | ||
| Q4 24 | 67.3% | — | ||
| Q3 24 | 67.1% | — | ||
| Q2 24 | 67.4% | — | ||
| Q1 24 | 68.9% | — |
营业利润率FIGSRARE
| Q4 25 | 9.3% | -54.7% | ||
| Q3 25 | 6.4% | -106.9% | ||
| Q2 25 | 6.5% | -64.8% | ||
| Q1 25 | -0.2% | -102.6% | ||
| Q4 24 | 5.9% | -74.3% | ||
| Q3 24 | -6.2% | -94.6% | ||
| Q2 24 | 1.1% | -79.1% | ||
| Q1 24 | 0.4% | -151.9% |
净利率FIGSRARE
| Q4 25 | 9.2% | -62.0% | ||
| Q3 25 | 5.8% | -112.8% | ||
| Q2 25 | 4.7% | -69.0% | ||
| Q1 25 | -0.1% | -108.5% | ||
| Q4 24 | 1.2% | -80.9% | ||
| Q3 24 | -1.2% | -95.7% | ||
| Q2 24 | 0.8% | -89.5% | ||
| Q1 24 | 1.2% | -156.8% |
每股收益（稀释后）FIGSRARE
| Q4 25 | $0.10 | $-1.28 | ||
| Q3 25 | $0.05 | $-1.81 | ||
| Q2 25 | $0.04 | $-1.17 | ||
| Q1 25 | $0.00 | $-1.57 | ||
| Q4 24 | $0.01 | $-1.34 | ||
| Q3 24 | $-0.01 | $-1.40 | ||
| Q2 24 | $0.01 | $-1.52 | ||
| Q1 24 | $0.01 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $437.5M | $-80.0M |
| 总资产 | $580.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FIGSRARE
| Q4 25 | $82.0M | $421.0M | ||
| Q3 25 | $46.5M | $202.5M | ||
| Q2 25 | $50.8M | $176.3M | ||
| Q1 25 | $90.0M | $127.1M | ||
| Q4 24 | $85.6M | $174.0M | ||
| Q3 24 | $124.1M | $150.6M | ||
| Q2 24 | $131.8M | $480.7M | ||
| Q1 24 | $155.3M | $112.3M |
股东权益FIGSRARE
| Q4 25 | $437.5M | $-80.0M | ||
| Q3 25 | $413.3M | $9.2M | ||
| Q2 25 | $396.5M | $151.3M | ||
| Q1 25 | $381.5M | $144.2M | ||
| Q4 24 | $377.1M | $255.0M | ||
| Q3 24 | $403.5M | $346.8M | ||
| Q2 24 | $401.7M | $432.4M | ||
| Q1 24 | $389.9M | $140.3M |
总资产FIGSRARE
| Q4 25 | $580.0M | $1.5B | ||
| Q3 25 | $544.7M | $1.2B | ||
| Q2 25 | $517.1M | $1.3B | ||
| Q1 25 | $522.3M | $1.3B | ||
| Q4 24 | $509.8M | $1.5B | ||
| Q3 24 | $542.5M | $1.5B | ||
| Q2 24 | $526.0M | $1.6B | ||
| Q1 24 | $510.9M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $58.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 28.8% | -48.6% |
| 资本支出强度资本支出/营收 | 1.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 3.29× | — |
| 过去12个月自由现金流最近4个季度 | $53.0M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流FIGSRARE
| Q4 25 | $60.9M | $-99.8M | ||
| Q3 25 | $3.4M | $-91.4M | ||
| Q2 25 | $-12.4M | $-108.3M | ||
| Q1 25 | $9.2M | $-166.5M | ||
| Q4 24 | $30.4M | $-79.3M | ||
| Q3 24 | $22.6M | $-67.0M | ||
| Q2 24 | $16.5M | $-77.0M | ||
| Q1 24 | $11.6M | $-190.7M |
自由现金流FIGSRARE
| Q4 25 | $58.1M | $-100.8M | ||
| Q3 25 | $531.0K | $-92.7M | ||
| Q2 25 | $-13.5M | $-110.7M | ||
| Q1 25 | $7.9M | $-167.8M | ||
| Q4 24 | $27.1M | $-79.5M | ||
| Q3 24 | $18.4M | $-68.6M | ||
| Q2 24 | $7.5M | $-79.0M | ||
| Q1 24 | $11.1M | $-193.9M |
自由现金流率FIGSRARE
| Q4 25 | 28.8% | -48.6% | ||
| Q3 25 | 0.4% | -58.0% | ||
| Q2 25 | -8.9% | -66.5% | ||
| Q1 25 | 6.3% | -120.5% | ||
| Q4 24 | 17.8% | -48.3% | ||
| Q3 24 | 13.1% | -49.2% | ||
| Q2 24 | 5.2% | -53.7% | ||
| Q1 24 | 9.3% | -178.2% |
资本支出强度FIGSRARE
| Q4 25 | 1.4% | 0.5% | ||
| Q3 25 | 1.9% | 0.8% | ||
| Q2 25 | 0.7% | 1.5% | ||
| Q1 25 | 1.0% | 1.0% | ||
| Q4 24 | 2.2% | 0.1% | ||
| Q3 24 | 3.0% | 1.2% | ||
| Q2 24 | 6.2% | 1.4% | ||
| Q1 24 | 0.4% | 3.0% |
现金转化率FIGSRARE
| Q4 25 | 3.29× | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | -1.75× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 16.14× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 15.04× | — | ||
| Q1 24 | 8.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FIGS
| Scrubwear | $154.9M | 77% |
| Non Scrubwear Lifestyle | $47.0M | 23% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
